Sartorius Stedim Biotech Stock price

Equities

DIM

FR0013154002

Medical Equipment, Supplies & Distribution

Real-time Euronext Paris 12:39:48 2024-03-28 pm EDT 5-day change 1st Jan Change
264.3 EUR +0.76% Intraday chart for Sartorius Stedim Biotech -4.27% +10.35%
Sales 2024 * 3B 3.24B Sales 2025 * 3.44B 3.71B Capitalization 25.72B 27.72B
Net income 2024 * 359M 387M Net income 2025 * 497M 536M EV / Sales 2024 * 9.57 x
Net Debt 2024 * 3.03B 3.27B Net Debt 2025 * 2.79B 3B EV / Sales 2025 * 8.28 x
P/E ratio 2024 *
69.6 x
P/E ratio 2025 *
50.6 x
Employees 10,662
Yield 2024 *
0.29%
Yield 2025 *
0.39%
Free-Float 31.97%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Sartorius Stedim Biotech

1 day+0.76%
1 week-4.27%
Current month+3.93%
1 month+5.34%
3 months+10.26%
6 months+19.70%
Current year+10.35%
More quotes
1 week
255.10
Extreme 255.1
279.70
1 month
246.20
Extreme 246.2
281.00
Current year
216.00
Extreme 216
281.00
1 year
160.55
Extreme 160.55
310.80
3 years
160.55
Extreme 160.55
551.00
5 years
106.20
Extreme 106.2
551.00
10 years
20.00
Extreme 20
551.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 19-03-25
Chairman 58 07-06-28
Chief Tech/Sci/R&D Officer 59 09-04-28
Members of the board TitleAgeSince
Director/Board Member 62 07-06-28
Chairman 58 07-06-28
Director/Board Member 67 15-04-06
More insiders
Date Price Change Volume
24-03-28 264.3 +0.76% 48,852
24-03-27 262.3 -1.91% 86,086
24-03-26 267.4 -1.40% 49,596
24-03-25 271.2 -3.14% 54,114
24-03-22 280 +1.41% 37,454

Real-time Euronext Paris, March 28, 2024 at 12:39 pm EDT

More quotes
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
264.3 EUR
Average target price
261.2 EUR
Spread / Average Target
-1.16%
Consensus
  1. Stock
  2. Equities
  3. Stock Sartorius Stedim Biotech - Euronext Paris